Key result
Extracellular application of arachidonic acid (50 microM) enhanced both early transient and late persistent components of voltage-dependent K+ currents by 15-29% in rat neocortical neurones.
Arachidonic acid enhances voltage-dependent potassium currents in rat neocortical neurons, an effect that is blocked by indomethacin, suggesting involvement of the cyclooxygenase pathway.
Answers are grounded in this paper and cite their sources.
No immediate clinical implications; leaves open whether arachidonic acid modulates human neocortical K+ currents via COX.
We analysed the effects induced by arachidonic acid on voltage-dependent outward currents generated by rat neocortical neurones in culture in the presence of Na+ and Ca2+ channel blockers. These currents, recorded with whole-cell voltage-clamping techniques, were presumably carried by K+ and were characterized by an early transient and a late persistent component. Extracellular application of arachidonic acid (50 microM) enhanced both components of the voltage-dependent K+ response by 15-29% (n > 20 cells). These effects were reversible and not observed when a low dose (50 microM) of indomethacin was present in the bath (n = 7 cells). We conclude that one or more of the arachidonic acid metabolites of the cyclooxygenase pathway might be involved in the modulation of outward currents in neocortical cells in culture.
No takes yet. Share an insight, caveat, or question.
Zona et al. (1993) studied this question. Arachidonic acid vs. Baseline / Indomethacin was evaluated on Voltage-dependent outward currents (early transient and late persistent components) (15-29% enhancement). Extracellular application of arachidonic acid (50 microM) enhanced both early transient and late persistent components of voltage-dependent K+ currents by 15-29% in rat neocortical neurones.
Synapse has enriched 10 related papers. Consider them for comparative context: